MTM Vision Fall 2024 Symposium | Therapeutics Target Identification Through Human Tissue and Fluid ‘Omics

MTM Vision Update:  Patrice Fort, PhD  Director, MTM Vision Ocular Biorepository & Resource Center

Perspectives

  • Roger Cone, PhD  Mary Sue Coleman Director & Research Professor; Vice Provost and Director, U-M Life Sciences Institute; Professor, Department of Molecular & Integrative Physiology, U-M Medical School; Professor, Molecular, Cellular, and Developmental Biology, LSA. Process and resources for target identification and drug development.
  • Przemyslaw (Mike) Sapieha, PhD  Founder & Chief Scientific Officer, SemaThera Inc. From target identification to drug development for ocular diseases.

Panelists

  • Lloyd Paul Aiello, MD, PhD  Harvard Medical School
  • Eric Ng, PhD | Eyebiotech Limited, a subsidiary of Merck & Co, Inc (Rahway, NJ)
  • Subramaniam Pennathur, MD University of Michigan
  • Judy Hunt, MBA MTM Vision Lay Advisor